![Hugh Wynne-Edwards](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hugh Wynne-Edwards
Career history of Hugh Wynne-Edwards
Former positions of Hugh Wynne-Edwards
Companies | Position | Start | End |
---|---|---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Chairman | - | 2008-04-07 |
BC Research, Inc.
![]() BC Research, Inc. Miscellaneous Commercial ServicesCommercial Services BC Research, Inc. provides clinical research services. Its services include custom research, engineering, plant services and process commercialization services. The company is headquartered in Vancouver, Canada. | Founder | 1992-12-31 | - |
Training of Hugh Wynne-Edwards
University of Aberdeen | Undergraduate Degree |
Queen's University | Doctorate Degree |
Statistics
International
Canada | 4 |
United Kingdom | 2 |
Operational
Chairman | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
BC Research, Inc.
![]() BC Research, Inc. Miscellaneous Commercial ServicesCommercial Services BC Research, Inc. provides clinical research services. Its services include custom research, engineering, plant services and process commercialization services. The company is headquartered in Vancouver, Canada. | Commercial Services |
- Stock Market
- Insiders
- Hugh Wynne-Edwards
- Experience